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Abstract
Endothelial cells (ECs) play a critical role in regulating vascular pathophysiology. 
Various growth factors and relaxation factors such as vascular endothelial growth fac-
tor (VEGF) and nitric oxide (NO), which are derived from ECs, are known to maintain 
homeostasis and regulate vessel remodeling. Although the inner lumens of all types of 
vessels are covered by an EC monolayer, the characteristics of ECs differ in each tissue 
and developing stage of a vessel. Previously, we identified the heterogeneity of ECs of the 
ductus arteriosus (DA) by analyzing its gene profiles. The DA is a fetal artery that closes 
immediately after birth due to the changes in concentrations of oxygen and vasoactive 
factors such as NO and prostaglandin E. Studying the unique gene profile of ECs in the 
DA can therefore uncover the novel key genes involved in developing vascular func-
tion and morphology such as O
2
 sensitivity and physiological vascular remodeling. A 
comprehensive gene analysis identified a number of genes related to morphogenesis and 
development in the DA. In this chapter, we discuss the heterogeneity of vascular ECs in 
the developing vessel in the DA.
Keywords: vascular endothelial cells, ductus arteriosus, vascular remodeling, 
comprehensive gene analysis, oxygen, vitamin A
1. Introduction
The endothelial cells (ECs) in vessels control the vascular tone, permeability, attraction of 
blood cells, which exhibit both innate and adaptive immunity, and migration/prolifera-
tion of underlying cells such as pericytes and smooth muscle cells (SMCs). To accomplish 
these roles, vascular ECs exhibit phenotypic heterogeneity during development in a time- 
and tissue-specific manner. The most significant diversity of ECs involves the differences 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativeco mons.org/licen es/by/3.0), w ich permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
between arteries and veins as well as between large and small vessels. ECs undergo constant 
changes in phenotype depending on different situations, both physiological and pathological. 
Physiological angiogenesis occurs during development and repair processes. Many events 
in vascular development during gestation are reciprocated in the adult neovascularization 
that takes place in wound healing and ischemic disease treatment. In these cases, ECs must 
express pro-angiogenic factors. Pathological angiogenesis is often implicated as the abnormal 
proliferation of ECs such as that seen in tumorigenesis. Accordingly, many cancer studies 
have focused on vascular endothelial growth factor (VEGF), a pro-angiogenic factor produced 
from ECs. Endothelial damage and dysfunction causes cardiovascular diseases. For example, 
endothelial dysfunction reduces nitric oxide (NO) production, which decreases vasodilatory 
effects on SMCs. In addition, a decrease in NO production is also involved in the attraction 
of leucocytes and the production of various growth factors that leads to unregulated intimal 
thickening (Figure 1). Therefore, ECs play a central role in modifying the phenotypes of ves-
sels. ECs have different roles depending on where they are located. For instance, in a develop-
ing vessel, ECs become tip cells or other stalk cells to regulate different molecular signaling 
to guide vessel sprouting [1]. Endothelial tip cells coordinate to have less proliferative activ-
ity by repressing Notch activity, thus upregulating VEGFR-2 (Flk-1) and other  downstream 
Figure 1. Summarized pathological and physiological vessel response. Damaged ECs are shown in dark blue. Due 
to the damage, there is a reduction of NO and an increase of ROS, which leads to platelet aggregation or leukocyte 
adhesion to the intima. Cytokines produced from platelets or leukocytes induce growth factor production and cause 
SMC hyperplasia and contraction. By contrast, healthy ECs constantly produce EDRF such as NO, so that SMC mitogen 
and contraction are absent. In developing vessels, ECs are proliferating or deriving from progenitor cells. Proliferating 
ECs can be distinguished into stalk cells and tip cells, which have different downstream VEGF pathways depending on 
Notch activity.
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Notch transcription factors such as HASER1 [2]. By contrast, Notch signaling is more active 
and VEGFR-1 (Flt-1) expression is upregulated in stalk ECs. Although Notch and VEGF 
signals are greatly conserved in vessel sprouting among various tissues and species, how 
widespread it is in terms of tissue specificity remains to be elucidated (Figure 1). Increasing 
evidence shows that different signaling rules influence tissue-specific vessel sprouting—one 
study demonstrated that bone morphogenetic protein (BMP) signaling provides the cue for 
vein-specific angiogenesis during early development, and is independent from canonical 
VEGF-A signaling [3]. Casanello et al. reported that endothelial diversity is also present in the 
umbilico-placental vasculature, and emphasized that the heterogeneity of ECs is complicated 
and cannot be explained simply by comparing the differences between micro- and macro-vas-
culature, or artery versus vein [4]. Thus, EC shows great heterogeneity in health and disease, 
and studying the mechanisms of EC heterogeneity would contribute to the understanding of 
both vascular physiology and pathology.
We previously revealed the unique gene profile of ductus arteriosus (DA)-specific ECs. The 
DA, a fetal artery that connects the pulmonary artery (PA) and the aorta, is essential for 
fetuses to bypass the oxygenated blood delivered from the placenta directly to the descending 
aorta and not through the lung. The DA experiences a dramatic morphological change along 
with environmental factors after birth, though other connecting arteries remain unchanged. 
Therefore, even under similar physiological stresses underlying the DA and its connecting 
arteries, heterogeneity of ECs must exist. In this chapter, we focus on reviewing the unique 
identified gene profile of DA ECs, which should provide novel insights into heterogeneity in 
vascular ECs.
Moreover, investigating DA remodeling would potentially help the understanding of dis-
eased vessels, just like other animal models in cardiovascular diseases. For instance, a wire 
injury model is used for studying pathology of endothelial injury/dysfunction [5]; low-den-
sity lipoprotein receptor-deficient mice [6] and apolipoprotein E-deficient mice [7] are com-
monly used as atherosclerosis models; calcium chloride [8], elastase [9], angiotensin II [10], or 
microRNA-21 [11] are infused to create an abdominal aortic aneurysms model. Developing 
a disease model occupies a great deal of scientific findings on pathophysiology, and so the 
existing models should always open to be refined. The DA can be an alternate model of an 
occluding vessel, an extracellular matrix (ECM)-enriched vessel, or an oxygen-sensitive ves-
sel. Thus, studying DA ECs would be valuable for understanding an irregular angiogenic 
pathophysiology.
1.1. Embryonic vasculogenesis
Vasculogenesis and angiogenesis are nomenclaturally similar as they both refer to the gen-
esis of blood vessels [12]. Vasculogenesis is the de novo formation of blood vessels differ-
entiated from mesodermal cells. Angiogenesis is the sprouting of blood vessels that occurs 
as a result of the proliferation of existing vascular ECs. Despite the difference in these two 
processes, vasculogenesis and angiogenesis are often compared to further understand 
their underlying molecular mechanisms. Indeed, a significant amount of knowledge on 
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tumor angiogenesis was achieved by studying embryonic vasculogenesis [13]. Therefore, 
it is important to study developmental vascular biology and to understand vessel-specific 
heterogeneity. Moreover, determining the heterogenic diversity of ECs would help open 
up more options in clinical therapy, ultimately enabling individually designed therapeutic 
treatments.
The vascular network is the first functional system established in the embryo. A primitive 
vascular network is formed shortly after gastrulation by deriving endothelial progenitor 
cells from the mesoderm. This first process is called the formation of angioblasts. Angioblasts 
then differentiate into ECs by expressing various transcription factors and pan endothelial 
markers for tubular formation, which is called the primitive vascular plexus [13]. Some of 
the homeobox (Hox) transcription factors are known to be involved in this process. For 
instance, Hox A9 regulates the expressions of endothelial NO synthase (eNOS), VEGF-
receptor 2 (VEGFR2), and vascular endothelial-cadherin (VE-cadherin), and is responsible 
for the tubulogenesis of mature ECs [14]. Hox B3 also plays a role in tubulogenesis [15]. Hox 
D3 induces the differentiation of ECs from angioblasts [16]. The primitive vascular plexus 
then undergoes complex remodeling accompanied by specification among arteries, veins, 
and capillaries to become the functional vascular system [13]. Sry-related HMG box (Soxs)-F 
subgroups Sox7, Sox17, and Sox18, along with vascular endothelial zinc finger-1 (Vezf-1), 
were found to be essential to the remodeling process [17, 18]. Thus, vasculogenesis in gen-
eral consists of three steps: formation of angioblasts, formation of the primitive vascular 
plexus, and vascular remodeling. During these steps, the heterogeneity of vascular ECs is 
established.
1.2. Physiology of the DA
After the vascular system appears during embryonic development, the heart starts to func-
tion, and fetal circulation is established. Fetal circulation is different from adult circulation 
since the blood is oxygenated in the placenta instead of the lung. Prenatal lungs do not yet 
need to function so the DA bypasses the pulmonary artery and the descending aorta to 
send most blood to the body instead of the lungs. Patency of the DA is maintained due to 
the low oxygen level and high concentration of prostaglandin E
2
 (PGE
2
) in the blood cir-
culated from the placenta, as well as the production of NO from ECs of the DA. Once the 
infant has been delivered and lung ventilation has begun, the DA must close properly to 
enable the transformation to adult circulation. Normal closure happens in two steps: func-
tional closure and anatomical occlusion [19]. The first closure is triggered by an increase 
in pO
2
 and a drop in PGE
2
, as well as a drop in blood pressure within the DA caused by 
the reduction in pulmonary vascular resistance. This functional closure causes the loss of 
blood flow which therefore induces hypoxia and extensive intimal thickening, followed by 
fibrosis. The hypoxia on the vessel wall further inhibits endogenous prostaglandin and NO 
production, which leads to an irreversible closure. Two to three weeks later, the sealed DA 
eventually becomes a fibrous band called the ligamentum arteriosum (Figure 2) [19]. Failed 
DA closure after birth is a condition called patent DA (PDA), and occurs frequently in 
premature infants. Medical or surgical treatment of PDA is required when the left-to-right 
blood shunt is significant.
Physiologic and Pathologic Angiogenesis - Signaling Mechanisms and Targeted Therapy178
2. Endothelial heterogeneity in terms of the DA
2.1. Current methodologies to study the heterogeneity of DA-specific ECs
The DA is a small shunt vessel in fetuses or neonates. The size of the tissue has always been a 
study limitation in small mammals such as rodent models. Therefore, although many previ-
ous studies used larger mammals such as lamb or pig fetuses, they are inefficient for conduct-
ing primary-level research due to the difficulty in handling, low number of offspring, and 
long gestational period. Rodents overcome these disadvantages, and experimental tools of 
molecular biology are more available for rodents. Thanks to advancements in technology, 
there are now more options than ever to overcome the limitation of tissue size in rodents.
2.1.1. Isolation of ECs of the rat DA
DA researchers have used different species, including baboon, pig, sheep, rabbit, chicken, 
rat, and mouse [20]. These studies focused on a specific population of the cells in the DA 
and always faced limitations in using rodent animals due to the small size of the fetal tissue. 
To date, there are only three studies in which pure ECs were successfully isolated from rat 
DA, including ours. Weber et al. applied a magnetic-activated cell sorting (MACS) method 
to purify the ECs from collagenase-digested DA tissue [20]. They used von Willebrand fac-
tor (vWF) polyclonal antibody in MACS for the isolation. With their experimental method, 
they succeeded in passaging a pure population of ECs up to three times, which overcame the 
small number of primary-cultured ECs for further experiments. Following the isolation, they 
confirmed the purification by flow cytometry and immunohistochemistry analyses. In our 
Figure 2. Representative pathways during DA remodeling. In early gestation, the DA remained open due to the high 
concentration of PGE
2
 from placental circulation, and by producing EDHF (NO and CO in the figure). Low oxygen 
concentration induced ET-1 signaling and TGF-β expression in ECs, leading to functional closure. Postnatal DA is 
exposed to oxygenated blood that has reduced concentrations of PGE
2
 and NO. Due to reduced NO production, ROS 
are produced and monocytes are attracted to the intima. Monocyte-endothelial interaction induces cytokine and growth 
factor upregulation, thus promoting SMC growth. Extensive neointimal formation at a later stage causes ischemic 
hypoxia and ATP depletion, and eventual cell death.
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previous study, we used a florescence-activated cell sorter (FACS) to purify ECs from col-
lagenase-digested DA tissues [21]. In this experiment, we incubated pooled fresh cells with 
fluorescein isothiocyanate (FITC)-conjugated anti-CD31 and APC/Cy7-conjugated anti-CD45 
antibodies to separate EC and hematopoietic derivation cells, respectively. We confirmed the 
purity by performing quantitative reverse transcription polymerase chain reaction (RT-PCR) 
for Tie2 and gamma2-actin expressions, which are markers of ECs and SMCs, respectively. 
After the FACS sorting, we proceeded directly to RNA isolation from the collected ECs for 
application to a DNA microarray experiment, which minimized differentiation of the isolated 
ECs after purification. More recently, a study focused on the heterogeneity of tissue-specific 
cells that separated ECs and SMCs from the DA using laser-capture microdissection [22].
2.1.2. Comprehensive gene expression analysis of DA tissues
During the past decade, several groups, including ours, have studied comprehensive gene 
expression in the DA using DNA microarray analysis. One study used human DA specimens, 
with a broad range of ages [23]. Because of the difficulty involved with human samples of 
the DA, they could not group the samples with biologic replicates. They found a tendency 
of expressing more genes that relate to ECM synthesis, which implied the presence of active 
neointimal proliferation in PDA. Other microarray studies used only rat vessels. Costa et al. 
compared rat DA samples from embryonic day 19 (E19) and 3 h after birth, examining the 
effects of oxygen [24]. Our group examined the expression profiles of rat DA and aorta at 
E19 and E21, and reported that the growth hormone (GH)-receptor signal is predominant in 
the SMCs of the DA [25]. We also investigated the effect of vitamin A maternal administra-
tion on the gene expression pattern of the DA at E19, E21 (full term), and 3–6 h after birth 
[26]. Moreover, our group utilized the unique phenotype of the Brown-Norway (BN) rat—
this strain has been characterized as a novel animal model for PDA possibly due to systemic 
elastin-related impairments—to compare with vessels of its control strain Fisher 344 [27]. 
Although all of these studies reported somewhat overlapping results, none could determine 
the EC-specific gene profiles. As discussed above, the EC layer is maintained to form a single 
layer; the majority of genes that appear on microarray analysis using whole tissue are there-
fore from SMC origin.
Because the analysis of the expression profiles of the vascular ECs of the DA is challenging, 
only two studies have been published to date, including ours [21, 22]. It is difficult to compare 
these two studies because we used pooled DA ECs purified by FACS, whereas Bokenkamp et 
al. used laser-capture microdissection to isolate DA ECs from a frozen sample. Accordingly, 
some of the study results are inconsistent. For example, Bokenkamp et al. demonstrated that 
the expression of Rgs5 mRNA was higher in the DA compared to the aorta [22], whereas we 
did not find a difference in Rgs5 expression between DA ECs and aortic ECs. In our study, 
we divided samples into four groups: the DA and aorta of E21 fetals (F group) and neonates 
30 min after birth (N group) rats. We further categorized the microarray data with GeneGo 
MetaCore software to clarify the meaning of enriched gene expressions. Interestingly, the 
majority of the identified DA-dominant genes had not previously been reported in previous 
DA-related studies. We review the unique gene profiles of DA-specific ECs in the following 
sections.
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2.2. Characteristics of DA-specific ECs in DA remodeling
As mentioned in the earlier section, the DA has special remodeling processes that differ from 
other vessels. Most research on DA remodeling has been conducted using the whole tissue 
or its SMCs. The importance of signals generated from blood or ECs has, however, begun to 
be realized.
2.2.1. Extracellular matrix remodeling of the DA
In the late 1980s, Rabinovitch’s group discovered that the intimal cushion formation of the DA 
is attributed to a special character in its cells [28, 29]. Using in vitro cells from lamb tissues, they 
demonstrated that there are 10-fold and five-fold increased incorporations of hyaluronan and 
heparansulfate in the ECM of DA ECs, respectively, compared to cells of the adjacent aorta or 
pulmonary artery (PA). They further found that this remodeling, which involves the increased 
hyaluronan accumulation in DA ECs, contributes to the migration of DA SMCs [30], and is 
transforming growth factor-beta (TGF-β)-dependent [31]. About a decade later, the same group 
reported that TGF-β1 expression in DA ECs was upregulated in the early gestation of fetal lambs 
compared to aortic ECs, but was downregulated to the same level as aortic ECs by late gestation 
[32]. This dynamic modification in the DA EC was explained to relate to stability in the trans-
lation and transcription of its mRNA. This second study provided some of the first evidence 
showing that there are tissue-specific and developmental patterns of expression in DA ECs.
The comprehensive gene analysis study identified significantly high expressions of N- 
deacetylase/N-sulfotransferase (Ndst3), Glipican 3(Gpc3), and heparan-sulfate 6-O-sulfo-
transferase 2 (Hs6st2), all of which are involved in heparasulfate synthesis, in DA ECs in 
both full-term fetal and neonatal periods [21]. Ndst3 is the most important heparin-sulfate 
synthase among the three members of the NDST family [33]. Other genes that are known to 
relate to ECM, especially collagen synthesis, were also found to show higher expression levels 
in DA ECs than aortic ECs: the glycosyltransferase25 domain containing 2 (Glt25d2), which 
is known to strengthen collagen activity [34]; growth differentiation factor (Gdf6), and micro-
fibrillar-associated protein 5 (Mfap5), which promotes collagen production [35, 36]; Mfap4, 
which stabilizes collagen activity [37]; anthrax toxin receptor 1 (Antxr1), which provides a 
link between collagen I and actin cytoskeleton [38]; and prolyl 4-hydroxylase-alpha polypep-
tide (P4ha1), which is related to the procollagen process [39]. ADAM metallopeptidase with 
thrombospondin type 1 motif-17 preproprotein (Adamts17), plasminogen activator tissue 
(Plat), and fibrillin 1 (Fbn1), which are also categorized as related to ECM formation, were 
upregulated in DA ECs [21]. Interestingly, connective tissue growth factor (CTGF) was found 
to show higher expression in DA ECs than in aortic ECs in the postnatal period, whereas 
there was no difference in the fetal period [21]. CTGF is a well-known downstream mediator 
of TGF-β1 in various cells and it exhibits diverse functions, such as cell proliferation, apopto-
sis, cell adhesion, ECM or collagen production, and angiogenesis [40, 41]. Moreover, a recent 
study demonstrated that, via stimulation of TGF-β1, CTGF binds to VEGF, and that the com-
plex inhibited VEGF-mediated angiogenesis in cardiac cells [42]. Although further studies 
are needed, these results imply that there are intricate regulations among TGF-β1, CTGF, and 
VEGF in the DA remodeling after birth.
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2.2.2. PGE
2
, endothelial-derived relaxation, and hyperpolarizing factors in the DA
PGE
2
 is a potent vasodilator for the DA. It is generated by the enzyme cyclooxygenase (COX). 
There are two isoforms, COX-1 and COX-2. Although COX-2 is an inducible isoform that 
requires cytokine, both COX-1 and COX-2 are known to be involved in fetal development 
[43]. The expression levels of these two vary among species as well as the term of gestation. 
For instance, COX-2 is barely detected in the DA of fetal pig, but more dominantly regulates 
DA tone in fetal lamb by expressing it in ECs [43]. Another study found that there is a coop-
erative interaction between PGE
2
 and NO, an endothelial-derived relaxation factor (EDRF) 
[44]. Several studies showed that NO is more potent than PGE
2
 in the preterm DA, whereas 
the opposite relationship is seen at term [45–47]. Another EDRF that is found to be related to 
controlling DA tone is carbon monoxide (CO). CO is naturally formed in the body from the 
enzymatic activity of heme oxygenase (HO-1/2). Coceani et al. demonstrated that CO formed 
by HO (ECs of DA only express HO-1 in rat and pig fetuses) interfered with the reaction with 
the cytochrome P450-based monooxygenase and inhibited the synthesis of endothelin-1 (ET-
1), which is a potent vasoconstrictor that is also critical in DA tone [48–50]. CO generated from 
HO-1, but not HO-2, is known to have a protective effect on ECs of various vessels [51], and 
induces angiogenesis [52]. Importantly, compensatory mechanisms among PGE
2
, NO, and 
CO were elucidated by using eNOS, COX, or HO-2-mutant mice [53]. The study showed that 
there is no narrowing of the DA in each mutant, and that endothelial-derived hyperpolar-
izing factor (EDHF) additionally exhibits a large reciprocal effect [53]. In addition to bradyki-
nin, which has been shown to have the same relaxation effect as EDHF, there could be more 
agents potentially qualified as EDHF. A more recent study reported that hydrogen sulfide 
(H
2
S) also acts as EDHF by expressing its synthetic enzymes cystathionine-γ-lyase (CSE) and 
cystathionine-β-synthase (CBS) in the intima, likely ECs of the DA [54].
2.2.3. Inflammatory response in DA ECs during anatomic remodeling
Anatomic remodeling of the full-term DA shares similar features of inflammatory vascular 
disorders such as atherosclerosis. As a consequence of the functional closure of the DA, isch-
emic hypoxia of the muscle media is induced due to the loss of luminal and vasa vasorum 
blood flow. Therefore, ATP depletion causes cell death [55, 56] and VEGF induction increases 
the penetration of vasa vasorum into the DA muscle media [57]. Clyman’s group examined the 
inflammatory processes involved in the postnatal constriction of the DA [58]. They found that 
VLA4 integrin expressing mononuclear cells (CD14+/CD163+ cells [59]), in which the ligand 
is vascular cell adhesion molecule-1 (VCAM-1) in ECs, increased to adhere to the lumen of 
the DA after birth. Along with the increased monocytes recruitment, VCAM-1 and E-selectin 
expressions were also elevated in DA ECs after birth [58]. Unlike the pathophysiology of ath-
erosclerosis, the upregulation of P-selectin and intracellular adhesion molecule-1 (ICAM-1) 
induced by monocytes adhesion was not seen in the DA. Interestingly, VLA4+ mononuclear 
cell adhesion was found to predominantly regulate the extent of neointimal remodeling of the 
DA after birth, with T-lymphocyte adhesion to a lesser extent, but no neutrophil or platelet 
adhesion [58]. VCAM-1 and E-selectin were also induced by VEGF and several cytokines, 
such as TNF-α, IFN-γ, and CD154, likely due to the profound hypoxia in the DA wall after 
birth. These responses are also seen in atherosclerotic remodeling, but the pattern of gene 
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expression modification seemed less in DA closure since IL-1 and MCP-1 were not expressed 
in the closing DA [58]. Some researchers argue, however, that the inflammatory response dur-
ing DA closure may cause a failure in constriction after birth [58], because TNF-α and IL-6 are 
known to have potent vasodilatory effects [60–63].
The monocyte-endothelial cell interaction has been implicated to play a critical role in vascu-
lar pathogenesis by inducing platelet-derived growth factor (PDGF) secretion that promotes 
the migration of SMCs into neointima [64]. Indeed, PDGF-B chain expression upregulation 
was confirmed in DA tissues after birth, and was inhibited by blocking monocyte adhesion 
using anti-VLA-4 monoclonal antibody treatment [59]. Moreover, the regulator of G-protein 
signaling 5 (Rgs5) that was found to be enriched in both ECs and SMCs of DA at full-term 
gestation compared to adjacent aortic cells [22] was suggested to be negatively regulated by 
PDGF [65]. PDGF-dependent repression of Rgs5 leads to SMC migration and G protein-cou-
pled receptor-mediated-signaling pathways, such as mitogen-activated protein kinase activa-
tion, thus contributing to vessel contraction and remodeling [65]. The Rgs5 expression level in 
DA tissue after birth has not been studied, but it is reasonable to hypothesize that it would be 
decreased, likely due to increased PDGF secretion after birth. Further studies are required to 
elucidate the intricate effects of DA remodeling.
2.2.4. Epithelial/endothelial-to-mesenchymal transition-related gene expressions in the DA
Recent studies have suggested that epithelial/endothelial-to-mesenchymal transition (EMT/
EndMT)-related genes play an important role in DA closure [21, 66]. Our microarray study 
on FACS isolated ECs from rat DA revealed that Tgfb2, actin alpha 2 smooth muscle aorta 
(ACTA2), N-cadherin (cadherin 2 or Cdh2), and met proto-oncogene (hepatocyte growth fac-
tor receptor or Met), which are known to be related to the EMT process, are significantly 
expressed compared to the aortic ECs [21]. In accordance with this finding, ACTA2 mutation 
is well characterized in PDA [67]. Another study that showed the importance of BMP9 and 
BMP10 as circulating growth factors in DA postnatal closure also found that they induced 
expressions of EMT/EndMT-initiating transcription factors SNAI1, SNAI2, ZEB2, TWIST1, 
and FOXC2 in ECs [66]. The study found that treatment with a neutralizing anti-BMP10 anti-
body on BMP9 knockout mice led to reopening of the DA. BMP9 and BMP10 are members 
of the TGF-β family, and are known to be elevated in mice around birth [68]. They have high 
affinity to bind to activin receptor-like kinase 1(ALK1), which is an EC-specific receptor [69], 
and additionally upregulate the expressions of BMPR2, ActR2A, and the co-receptor endoglin 
as well in the DA [66]. Moreover, BMP9 is reported to upregulate COX-2 and hyaluronic acid 
synthase 2 (HAS2) expressions, but not COX-1 [66, 70, 71]. Therefore, EMT or EndMT induced 
by BMP9 and BMP10 is thought to be a necessary process for anatomical closure of the DA.
Although it remains to be proved whether ECs at the lumen of closing DA would differenti-
ate into mesenchymal cells, Levet et al. observed that there is a loss of EC-specific marker 
(PECAM or CD31)-positive cells at the lumen [66]. Since those cells at the lumen had an 
autophagic appearance, the authors speculated that the loss of ECs is at least partially due to 
cell death. However, it is also reasonable to assume that the EC loss is attributed to EndMT 
which resulted in loss of the EC characteristics.
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2.3. Genetic responses to external stimuli on the DA and other vessels
The DA encounters great environmental changes during the perinatal period. Interestingly, 
the DA dramatically changes its morphology despite other neighboring arteries remaining 
unchanged. Therefore, it is reasonable to assume that the DA is sensitive to external or  internal 
stimuli, which are primarily received by cells at the lumen, more than other neighboring arteries.
2.3.1. Response to oxygen
In fetal life when the lungs are not yet ventilated, the resistance of pulmonary vessels is high. 
Therefore, most of the blood that is oxygenated from the placenta passes to the descending aorta 
through the DA. At birth, in accordance with lung expansion, the blood passing via the DA is 
reduced, since the resistance of the pulmonary arteries is lower than that of the systemic arter-
ies. In addition, an increase in oxygen concentration of the blood and a decrease in PGE
2
 levels 
trigger the contraction of the DA. Our previous study demonstrated that α1G, a T-type voltage-
dependent Ca2+ channel, mediates oxygenation-induced closure of the DA after birth [72].
Furthermore, as the neonatal period progresses, the DA constricts more and the vascular cells 
undergo hypoxic changes. As a result of hypoxia, reactive oxygen species (ROS) are gener-
ated by converting O
2
 to O
2
•− by NADPH oxidase in ECs. Further activated redox-signaling 
pathways increase the tyrosine and serine/threonine phosphorylation of proteins, and result 
in various physiological and pathophysiological responses that are reviewed elsewhere [73]. 
VEGF is one of the best known genes that are elevated in response to hypoxia in the DA, 
which contributes to the ingrowth of vasa vasorum and neointimal proliferation [57].
Our microarray analysis identified a significant number of genes that more closely relate 
to oxygen in DA ECs than in aortic ECs. Aldehyde dehydrogenase 1 family-member A1 
(Aldh1a1), aldolase C-fructose-bisphosphate (Aldoc), and CD38 are oxygen-related enzymes, 
and Vegfa, Tgfb2, and Ctgf are oxygen-related receptor ligands [21]. CD38 has been recently 
implicated to regulate Ca2+ signaling in response to ROS generation in pulmonary arterial 
SMCs [74]. Therefore, it would be interesting to examine the importance of CD38 in the DA.
2.3.2. Response to retinoic acid
Retinoic acid (RA), a metabolite of vitamin A, plays a critical role in organogenesis, such as 
the formation of the face, heart, eyes, limbs, and nervous systems [75]. Vitamin A maternal 
administration has been proven to increase the activities of vessel-contractile proteins and 
to accelerate the development of the O
2
-sensing mechanism in the DA [76]. Yokoyama et al. 
compared gene expression profiles by microarray in the DA in the presence or absence of 
maternal vitamin A administration at different developmental stages, and found that 91 genes 
in total responded to the treatment [26]. In addition to the genes that were previously dem-
onstrated to be induced by RA, such as fibronectin-1 and HAS2, the study also found that 
vitamin A treatment promoted the maturation of functions and structure of the DA. They also 
identified that VEGFA was increased by vitamin A administration.
Our microarray study on ECs from the DA versus the aorta also revealed the response to 
vitamin A to be one of the most dominant biological processes that worked in DA ECs [21]. 
TGF-beta 2, CD38, Ald1a1, Sp100, paired-like homeodomain 2-transcript variant 2 (Pitx2), 
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fatty acid desaturase 1 (Fads1), and dickkopf homolog 1 (Dkk1) were listed in the category. 
Although the MetaCore system did not mention it, lecithin-retinol acyltransferase (Lrat) was 
also increased in DA ECs. Indeed, Lrat was identified as one of the most significant expres-
sions in DA ECs, as it had a more than five-fold increase compared to aortic ECs. Given the 
fact that Lrat is the predominant enzyme in retinoid absorption [77], it is reasonable to think 
that this gene could play a great role in the DA having higher sensitivity to RA.
2.4. Other genes uniquely expressed in DA ECs
Our previous study identified more than 80 genes that were expressed more than two-fold or 
greater in ECs of the DA compared to those of the aorta, in both terms (F and N) [21]. In this sec-
tion, DA EC-unique genes that were not mentioned in the earlier section will be summarized.
2.4.1. Neural crest cell-related genes during development
The DA derives from neural crest cells that are located in the sixth pharyngeal arch artery 
[78, 79], which is one of the progenitors of the second heart field [78, 79]. We identified that 
Tbx1, a major transcriptional factor in the second heart field, was expressed approximately 
four-fold more in DA ECs compared to aortic ECs. Pitx2 and Fgf10, which are known to 
co-express with Tbx1 [80, 81], also showed more than two-fold expressions in DA ECs than 
in aortic ECs. Indeed, Momma suggested that the deletion of human chromosome 22q11.2, 
where Tbx1 is, increased DA anomalies [82]. Moreover, cadherin 2 (Cdh2), which is known 
to work downstream of Pitx2 [83], and Ephrin B1 (Efnb1), Hs6st2, and Isl1, which are known 
to be in the Fgf10 signaling pathway [84–86], were also expressed dominantly in DA ECs [21].
2.4.2. Solute carrier family 38, member 1 (Slc38a1)
Slc38a1 is a highly homologous protein subtype of placental system A, a Na+-dependent 
amino acid transporter that contributes to nutrient fetal growth, by expressing in the pla-
centa [87]. Placental system A activity increases along with the progression of pregnancy and 
therefore coincides with demands of fetal nutrient [88]. Slc38a1 was found to be one of the 
most dominant genes in DA ECs compared to aortic ECs [21]. Slc38a1 itself has not been fully 
characterized yet and has not been implicated in studies in the DA. Recently, using siRNA 
technology on cytotrophoblast cells, Slc38a1 was revealed to be a key contributor to total 
system A activity in term placenta [87]. Hence, the fact that Slc38a1 expressed approximately 
seven-fold more in DA ECs than in aortic ECs at full-term gestation implies its involvement 
in the vascular remodeling of the DA. Further study is needed to identify the role of Slc38a1 
in the DA during development.
2.4.3. Calpain-6
The calpain family is a calcium-dependent cysteine protease that is ubiquitously expressed 
in human tissues. Calpain-6 was identified about two decades ago; it has special features that 
make it stand out from other family members [89]. Calpain-6 is the only family member that 
lacks a calmodulin-like domain; it therefore has no protease active site [89]. Calpain-6 was 
exclusively but highly expressed during embryogenesis [90] and in placenta in 50 adult tis-
sues [89] (no DA examination). Our microarray study identified that calpain-6 was also one 
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of the most strongly expressed genes in DA ECs compared to aortic ECs, especially in fetal 
tissue [21]. Calpain-6 was recently implicated in tumor angiogenesis. Specifically, calpain-6 is 
suggested to play an important role in bone tumorigenesis and metastasis [91]. In the study, 
calpain-6 was found to be upregulated by ET-1, and to provide a protective effect against cell 
apoptosis and promote cell proliferation [91]. As mentioned earlier, ET-1 is increased in the 
DA to regulate its vasoconstriction [48–50]. Therefore, calpain-6 might be a newly identified 
gene in ET-1 signaling generated in DA ECs.
3. Conclusion
Studying EC heterogeneity aids our understanding of the physiology and pathophysiology 
of angiogenesis. It also has great potential to identify novel ways to regulate angiogenesis 
for treatment purposes. Comprehensive gene analysis using a microarray made it possible 
to reveal many genes that were previously functionally unidentified in tissue or disease. 
Molecular analyses using whole tissues hinder the data on specific cell types. ECs are the key 
cells responsible for primarily generating signaling pathways to modulate the functions or 
structure of a vessel. Vessels mainly consist of a medial layer (the majority of which is com-
posed of SMCs), and a single layer of ECs. The separation of ECs would therefore be the first 
hurdle to overcome in order to acquire data on ECs.
This chapter focused on reviewing the current knowledge of DA ECs, since we believe that 
the DA could be utilized as a vessel model for studying the mechanisms of both neointimal 
formation and apoptosis in addition to embryonic vasculogenesis. DA-specific ECs are highly 
unique compared to aortic ECs in terms of their heterogeneity. DA ECs have a great number 
of specific genes related to ECM formation, inflammatory response, EMT or EndMT, and 
oxygen and retinoic acid response. DA ECs also have more genes that are conserved from 
embryogenesis compared to adjacent aortic ECs. In our previous study, Slac38a1, Capn6, and 
Lrat were found to be the most significantly expressed genes in DA ECs. Although much 
more research is required to validate the importance of these newly identified dominant 
genes in DA ECs, we expect that these findings will promote further studies on PDA, thera-
peutic angiogenesis, and cancer treatment.
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